Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.76% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CTKB · Dec 31, 2024
Cytek Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-25-008780General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.66% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
3.85% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
21.90% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
55.43% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-10.24% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
19.66% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
13.39% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History21 statesSelf-history eligible
Sep 30, 20210/7 normalizedLevel 3Dec 31, 20210/7 normalizedLevel 3Mar 31, 20220/7 normalizedLevel 3Jun 30, 20220/8 normalizedLevel 3Sep 30, 20220/8 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20235/8 normalizedLevel 3Sep 30, 20237/8 normalizedLevel 3Dec 31, 20237/8 normalizedLevel 3Mar 31, 20247/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 1.96%
- Current
- 1.76%
- Delta
- -0.20%
- Previous
- 25.67%
- Current
- 12.66%
- Delta
- -13.01%
- Previous
- 7.29%
- Current
- 3.85%
- Delta
- -3.44%
- Previous
- 90.87%
- Current
- 21.90%
- Delta
- -68.98%
- Previous
- 56.32%
- Current
- 55.43%
- Delta
- -0.89%
- Previous
- -8.25%
- Current
- -10.24%
- Delta
- -1.99%
- Previous
- 19.19%
- Current
- 19.66%
- Delta
- 0.47%
- Previous
- 13.70%
- Current
- 13.39%
- Delta
- -0.30%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CTKB Fundamental State →Transitioned To · CTKB Fundamental State →Transitioned To · CTKB CAPEX_INTENSITY_DECREASED →Transitioned To · CTKB CASH_GENERATION_DECREASED →Transitioned To · CTKB GROWTH_DECREASED →Transitioned To · CTKB INVENTORY_PRESSURE_DECREASED →Transitioned To · CTKB MARGIN_DECREASED →Transitioned To · CTKB PROFITABILITY_DECREASED →Transitioned To · CTKB R_AND_D_INTENSITY_INCREASED →Transitioned To · CTKB SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.